107 related articles for article (PubMed ID: 2350992)
1. Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".
Filip K; Malý J; Horký J; Tlustáková M; Kálal J; Vrána M
Czech Med; 1990; 13(1):34-7. PubMed ID: 2350992
[TBL] [Abstract][Full Text] [Related]
2. [Artificial liver support system: removal of bilirubin and bile acids by hemoperfusion with ionex-column].
Hamaguchi M
Nihon Geka Gakkai Zasshi; 1983 Jan; 84(1):63-73. PubMed ID: 6674764
[TBL] [Abstract][Full Text] [Related]
3. Serum bile acid analysis in dogs with experimentally induced cholestatic jaundice.
Rutgers HC; Stradley RP; Johnson SE
Am J Vet Res; 1988 Mar; 49(3):317-20. PubMed ID: 3358542
[TBL] [Abstract][Full Text] [Related]
4. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
Omori Y
Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990
[TBL] [Abstract][Full Text] [Related]
5. Hematologic and biochemical abnormalities associated with induced extrahepatic bile duct obstruction in the cat.
Center SA; Baldwin BH; King JM; Tennant BC
Am J Vet Res; 1983 Oct; 44(10):1822-9. PubMed ID: 6638641
[TBL] [Abstract][Full Text] [Related]
6. Removal of bilirubin and bile acid with a new anion exchange resin: experimental background and clinical experiences.
Idezuki Y; Hamaguchi M; Hamabe S; Moriya H; Nagashima T; Watanabe H; Sonoda T; Teramoto K; Kikuchi T; Tanzawa H
Trans Am Soc Artif Intern Organs; 1981; 27():428-33. PubMed ID: 7331107
[No Abstract] [Full Text] [Related]
7. Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice.
Pazzi P; Scagliarini R; Puviani AC; Lodi G; Morsiani E; Gullini S
Int J Artif Organs; 2000 May; 23(5):312-8. PubMed ID: 10872849
[TBL] [Abstract][Full Text] [Related]
8. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
9. Effects of serial resin hemoperfusion in fulminant hepatic failure.
Bihari D; Hughes RD; Gimson AE; Langley PG; Ede RJ; Eder G; Williams R
Int J Artif Organs; 1983 Nov; 6(6):299-302. PubMed ID: 6668092
[TBL] [Abstract][Full Text] [Related]
10. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
[TBL] [Abstract][Full Text] [Related]
11. Bile constituents in blood and lymph during biliary obstruction. II. The absorption and transport of bile acids and bilirubin.
Szabó G; Magyar Z; Szentirmai A; Jakab F; Mihaly K
Lymphology; 1975 Jun; 8(2):36-42. PubMed ID: 1160386
[TBL] [Abstract][Full Text] [Related]
12. Investigation of bilirubin removal by NK-110 resin hemoperfusion in jaundiced dogs.
Ji-Chang S; Shao-Cheng Q; Chen-Yang Z; Fu-Hua N; Shao-Ming H; Tao L; Run-Hai C; Chang-Zhi C; Ming-Rong T; Hui-Ming W
Int J Artif Organs; 1986 Sep; 9(5):327-30. PubMed ID: 3781664
[TBL] [Abstract][Full Text] [Related]
13. Bile acid clearance and biocompatibility of XAD-4 haemoperfusion.
Bolhuis PA; Sinaasappel M
Int J Artif Organs; 1978 May; 1(3):135-41. PubMed ID: 689756
[TBL] [Abstract][Full Text] [Related]
14. Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog.
Center SA; Baldwin BH; Erb HN; Tennant BC
J Am Vet Med Assoc; 1985 Nov; 187(9):935-40. PubMed ID: 4055519
[TBL] [Abstract][Full Text] [Related]
15. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure.
Weber V; Linsberger I; Hauner M; Leistner A; Leistner A; Falkenhagen D
Biomacromolecules; 2008 Apr; 9(4):1322-8. PubMed ID: 18345636
[TBL] [Abstract][Full Text] [Related]
16. [Plasmaperfusion through activated charcoal and amberlite XAD-7 in dogs with liver failure induced by yellow phosphorus (author's transl)].
Horak W; Polterauer P; Renner F; Silberbauer K; Rauhs R; Mühlbacher F; Funovics J
Z Gastroenterol; 1979 Feb; 17(2):90-8. PubMed ID: 425590
[TBL] [Abstract][Full Text] [Related]
17. Sequential changes of bile contents in patients with obstructive jaundice from different etiologies.
Chen CY; Shiesh SC; Su WC; Chang KK; Lin XZ
Hepatogastroenterology; 1996; 43(10):796-9. PubMed ID: 8884292
[TBL] [Abstract][Full Text] [Related]
18. [Removal of bile acids by the method of hemosorption and lymphosorption in patients with extrahepatic cholestasis].
Lur'e BL; Lobakov AI; Repina SI; Ivanov AS; Mironova LA
Sov Med; 1984; (12):36-9. PubMed ID: 6523231
[No Abstract] [Full Text] [Related]
19. Removal of protein-bound substance in hepatic failure: polyetherurethane sheet embedded with powdered charcoal (UPC).
Kawanishi H; Tsuchiya T; Nishiki M; Sugiyama M; Ezaki H
Int J Artif Organs; 1984 Nov; 7(6):343-8. PubMed ID: 6526530
[TBL] [Abstract][Full Text] [Related]
20. Treatment of extrahepatic occlusive jaundice with activated charcoal hemoperfusion in dogs.
Lie TS; Kim WI; Holst A; Grünn U; Rommelsheim K
Acta Hepatogastroenterol (Stuttg); 1976; 23(4):262-6. PubMed ID: 970083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
